Interim Condensed Consolidated Statements of Changes in Equity (unaudited) - CAD ($) $ in Millions |
Total |
Common shares [member] |
Issued capital [member]
Preferred shares and other equity instruments [member]
|
Issued capital [member]
Common shares [member]
|
Treasury instruments [member]
Preferred shares and other equity instruments [member]
|
Treasury instruments [member]
Common shares [member]
|
Retained earnings [member] |
Other components of equity [member] |
Equity attributable to shareholders [member] |
Non-controlling interests [member] |
FVOCI securities and loans [member]
Other components of equity [member]
|
Foreign currency translation reserve [member]
Other components of equity [member]
|
Cash flow hedge reserve [member]
Other components of equity [member]
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at beginning of period at Oct. 31, 2024 | $ 127,192 | $ 9,020 | $ 21,013 | $ 11 | $ (61) | $ 88,608 | $ 8,498 | $ 127,089 | $ 103 | $ (897) | $ 7,128 | $ 2,267 | |
| Changes in equity | |||||||||||||
| Issues of share capital and other equity instruments | 3,142 | 3,104 | 58 | (20) | 3,142 | ||||||||
| Common shares purchased for cancellation | (1,781) | $ (155) | (155) | (1,626) | (1,781) | ||||||||
| Redemption of preferred shares and other equity instruments | (600) | (600) | (600) | ||||||||||
| Sales of treasury shares and other equity instruments | 7,359 | 3,141 | 4,218 | 7,359 | |||||||||
| Purchases of treasury shares and other equity instruments | (7,378) | (3,178) | (4,200) | (7,378) | |||||||||
| Share-based compensation awards | 23 | 58 | 23 | 23 | |||||||||
| Dividends on common shares | (6,344) | (6,344) | (6,344) | ||||||||||
| Dividends on preferred shares and distributions on other equity instruments | (394) | (355) | (355) | (39) | |||||||||
| Other | (27) | (27) | (27) | ||||||||||
| Net income | 14,935 | 14,930 | 14,930 | 5 | |||||||||
| Total other comprehensive income (loss), net of taxes | (495) | (218) | (277) | (495) | 73 | (116) | (234) | ||||||
| Balance at end of period at Jul. 31, 2025 | 135,632 | 11,524 | 20,916 | (26) | (43) | 94,971 | 8,221 | 135,563 | 69 | (824) | 7,012 | 2,033 | |
| Balance at beginning of period at Apr. 30, 2025 | 132,530 | 10,416 | 20,975 | (53) | (155) | 92,988 | 8,276 | 132,447 | 83 | (1,020) | 6,795 | 2,501 | |
| Changes in equity | |||||||||||||
| Issues of share capital and other equity instruments | 1,720 | 1,708 | 22 | (10) | 1,720 | ||||||||
| Common shares purchased for cancellation | (955) | (81) | (81) | (874) | (955) | ||||||||
| Redemption of preferred shares and other equity instruments | (600) | (600) | (600) | ||||||||||
| Sales of treasury shares and other equity instruments | 3,221 | 1,910 | 1,311 | 3,221 | |||||||||
| Purchases of treasury shares and other equity instruments | (3,082) | (1,883) | (1,199) | (3,082) | |||||||||
| Share-based compensation awards | 4 | 22 | 4 | 4 | |||||||||
| Dividends on common shares | (2,165) | (2,165) | (2,165) | ||||||||||
| Dividends on preferred shares and distributions on other equity instruments | (138) | (125) | (125) | (13) | |||||||||
| Other | 6 | 6 | 6 | ||||||||||
| Net income | 5,414 | 5,415 | 5,415 | (1) | |||||||||
| Total other comprehensive income (loss), net of taxes | (323) | (268) | (55) | (323) | 196 | 217 | (468) | ||||||
| Balance at end of period at Jul. 31, 2025 | 135,632 | 11,524 | 20,916 | (26) | (43) | 94,971 | 8,221 | 135,563 | 69 | (824) | 7,012 | 2,033 | |
| Balance at beginning of period at Oct. 31, 2025 | 139,151 | 11,643 | 20,863 | 32 | (110) | 96,938 | 9,726 | 139,092 | 59 | (265) | 7,613 | 2,378 | |
| Changes in equity | |||||||||||||
| Issues of share capital and other equity instruments | 1,504 | 1,361 | 148 | (5) | 1,504 | ||||||||
| Common shares purchased for cancellation | (4,236) | (257) | (257) | (3,979) | (4,236) | ||||||||
| Redemption of preferred shares and other equity instruments | (1,850) | (1,850) | (1,850) | ||||||||||
| Sales of treasury shares and other equity instruments | 10,142 | 2,831 | 7,311 | 10,142 | |||||||||
| Purchases of treasury shares and other equity instruments | (10,200) | (2,903) | (7,297) | (10,200) | |||||||||
| Share-based compensation awards | (88) | 148 | (88) | (88) | |||||||||
| Dividends on common shares | (7,009) | (7,009) | (7,009) | ||||||||||
| Dividends on preferred shares and distributions on other equity instruments | (425) | (419) | (419) | (6) | |||||||||
| Other | 13 | 13 | 13 | ||||||||||
| Net income | 17,318 | 17,313 | 17,313 | 5 | |||||||||
| Total other comprehensive income (loss), net of taxes | 774 | 713 | 61 | 774 | 0 | 188 | 265 | (392) | |||||
| Balance at end of period at Jul. 31, 2026 | 145,094 | 11,154 | 20,754 | (40) | (96) | 103,477 | 9,787 | 145,036 | 58 | (77) | 7,878 | 1,986 | |
| Balance at beginning of period at Apr. 30, 2026 | 140,773 | 11,154 | 20,760 | (16) | (121) | 101,243 | 7,697 | 140,717 | 56 | (205) | 6,188 | 1,714 | |
| Changes in equity | |||||||||||||
| Issues of share capital and other equity instruments | 78 | 78 | 78 | ||||||||||
| Common shares purchased for cancellation | (1,603) | (84) | (84) | (1,519) | (1,603) | ||||||||
| Sales of treasury shares and other equity instruments | 4,115 | 751 | 3,364 | 4,115 | |||||||||
| Purchases of treasury shares and other equity instruments | (4,114) | (775) | (3,339) | (4,114) | |||||||||
| Share-based compensation awards | (19) | $ 78 | (19) | (19) | |||||||||
| Dividends on common shares | (2,438) | (2,438) | (2,438) | ||||||||||
| Dividends on preferred shares and distributions on other equity instruments | (145) | (143) | (143) | (2) | |||||||||
| Other | 55 | 55 | 55 | ||||||||||
| Net income | 6,024 | 6,022 | 6,022 | 2 | |||||||||
| Total other comprehensive income (loss), net of taxes | 2,368 | 276 | 2,090 | 2,366 | 2 | 128 | 1,690 | 272 | |||||
| Balance at end of period at Jul. 31, 2026 | $ 145,094 | $ 11,154 | $ 20,754 | $ (40) | $ (96) | $ 103,477 | $ 9,787 | $ 145,036 | $ 58 | $ (77) | $ 7,878 | $ 1,986 |